A Phase II Study of Atezolizumab With or Without Bevacizumab vs Sunitinib in Untreated Metastatic Renal Cell Carcinoma Patients - 100098

Spotlight
Video

A Phase II Study of Atezolizumab With or Without Bevacizumab vs Sunitinib in Untreated Metastatic Renal Cell Carcinoma Patients

kidneycancer has 425 videos Subscribe Here

Loading........
Description: Thomas Powles MD of Barts Cancer Institute discusses the Phase II Study of Atezolizumab With or Without Bevacizumab vs Sunitinib in Untreated Metastatic Renal Cell Carcinoma Patients at the  12th European International Kidney Cancer Symposium 2017
Shared By : kidneycancer
Posted on : 04/25/17
Added : 10 months ago
Category : Kidney Cancer



Recommended

Nothing found.